Abstract
There has been considerable energy devoted to the study of epithelial cancer of the ovary during the last decade. Although the impact of this effort on the overall mortality from the disease has been depressingly small, advances have been made. The principles of surgical, radiotherapeutic and chemotherapeutic management are better understood, even if there is uncertainty about the precise place of each in the overall therapeutic armamentarium. There is also improved understanding of the patterns of spread of the disease and of the prognostic importance of several tumor-related variables. Recognizing the significance of these factors has brought out the complexity of evaluating the results of treatment. This is because results are often reported in a univariate mode, e.g., by stage, or residium, or grade, but not by considering several variables at once in a multivariate manner. A pioneering example of multifactorial analysis in ovarian cancer was presented by Griffiths, but for the most part the multifactorial presentation of treatment outcome has been avoided [la]. In many ways, however, those techniques of analysis which allow us to take account of several prognostic factors at once provide the clearest understanding of this disease. A valuable perspective on the place of radiotherapy in ovarian cancer can be gained by considering it in the light of these issues. Accordingly this essay will be in three sections, dealing with problems in interpreting results of treatment, the use of prognostic factors in classifying patients for prediction of treatment outcome and choice of therapy, and finally a critical review of a few selected trials of external beam radiation therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Griffiths CT: Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42:101–104, 1975.
Bush RS, Dembo AJ: Current status of treatment for patients with ovarian cancer. In: Ovarian Cancer, Advances in the Biosciences, Vol 26. Newman CE, Ford CHJ, Jordan JA (eds). Oxford: Pergamon Press, 1980, pp 115–135.
Easson EC, Russell MH: The cure of Hodgkin’s disease. Br Med J 1: 1704–1707, 1963.
Smith JP: Surgery for ovarian cancer. In: Ovarian Cancer, Advances in the Biosciences, Vol 26. Newman CE, Ford CHJ, Jordan JA (eds). Oxford. Pergamon Press, 1980, pp 137–149.
Bush RS, Allt WEC, Beale FA, Bean H, Pringle JF, Sturgeon J: Treatment of epithelial carcinoma of the ovary: operation, irradiation and chemotherapy. Am J Obstet Gynecol 127:692–704, 1977.
Dembo AJ, Sturgeon JR, Bean HA, Beale FA, Pringle JF, Brown TC, Gospodarowicz M, Bush RS: The effectiveness of adjuvant abdominopelvic irradiation in ovarian cancer. In: Adjuvant Therapy of Cancer II. Jones SE, Salmon SE (eds). New York: Grune & Stratton, 1979, pp 467–474.
Webb MJ, Decker DG, Mussey E, Wiliams TJ: Factors influencing survival in Stage I ovarian cancer. Am J Obstet Gynecol 116:222–226, 1973.
Ovarian Cancer Study Group Protocol for all Stage Ic and II (A, B, C) and Selected Stage IAii and IBii Ovarian Cancer: NCI Protocol #7602, June 1976.
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1–39, 1977.
Griffiths CT, Parker LM, Fuller AF: Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep 63:235–240, 1979.
Smith JP, Day TG: Review of ovarian cancer at the University of Texas Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute. Am J Obstet Gynecol 135:984–993, 1979.
Sturgeon JFG, Fine S, Gospodarowicz MK, Dembo AJ, Bean HA, Bush RS, Beale FA, Herman JG, Pringle JF, Thomas GM: A randomized trial of melphalan alone versus combination chemotherapy in advanced ovarian cancer. Gyn Oncol: Abstract 28, 268, 1980.
Ehrlich CE, Einhorn LH, Stehman FB, Roth LM, Blessing J: Responsive, ‘second look’ status and survival in Stage III-IV epithelial ovarian cancer treated with Cis-dichlorodiam-mine platinum II (Cis-platinum), adriamycin (ADR) and cytoxan (CTX). Gyn Oncol 10: Abstract 27, 367, 1980.
Young RC, Chabner BA, Hubbard SP, Fisher RI, Bender RA, Anderson T, Simon RM, Canellos GP, DeVita VT: Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med 229:1261–1266, 1978.
Dembo AJ, Bush RS, Beale FA, Bean HA, Pringle JF, Sturgeon J, Reid JG: Ovarian carcinoma: Improved survival following abdominopelvic irradiation in patients with a completed pelvic operation. Am J Obstet Gynecol 134:793–800, 1979.
Dembo AJ, Bush RS, Beale FA, Bean HA, Pringle JF, Sturgeon J: The Princess Margaret Study of Ovarian Cancer: Stages I, II and Asymptomatic III Presentation. Cancer Treat Rep 63:249–254, 1979.
Dembo AJ, VanDijk J, Japp B, Bean HA, Beale FA, Pringle JF, Bush RS: Whole abdominal irradiation by a moving-strip technique for patients with ovarian cancer. Int J Radiat Oncol Biol Phys 5:1933–1942, 1979.
Vogl SE, Pagano M, Kaplan BH, Canalog A, Greenwald E, Arseneau J: Combination chemotherapy of advanced ovarian cancer with cyclophosphamide (C), hexamethylmelamine (H), adriamycin (A) and diamminedichloroplatinum (C) - The ‘CHAD’ regimen. Gyn Oncol 10: Abstract 30, 369, 1980.
Edmonson JH, Fleming TR, Decker DG, Malkasian GD, Jorgensen EO, Jefferies JA, Webb MJ, Kvols LK: Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease. Cancer Treat Rep 63:241–247, 1979.
Rosenoff SH, Young RC, Anderson T, Bagley C, Chabner B, Schein PS, Hubbard S, DeVita VT: Peritoneoscopy: A valuable staging tool in ovarian carcinoma. Ann Int Med 83:37–41, 1975.
Piver MS, Barlow JJ, Lele SB: Incidence of subclinical metastasis in Stage I and II ovarian carcinoma. Obstet Gynecol 52:100–104, 1978.
Young RC: A strategy for effective management for early ovarian cancer. In: Adjuvant Therapy of Cancer II. Jones SE, Salmon SE (eds). New York: Grune&Stratton, 1979, pp 467–474.
Decker DG, Fleming TR, Malkasian GD, Webb MJ, Jefferies JA, Edmonson JH, Podratz KC, Gallenberg MM: A treatment program for Stage III and IV ovarian cancer. Cyclophosphamide versus cyclophosphamide and Cis-platinum. Gyn Oncol 10: Abstract 29, 368–369, 1980.
Smith JP, Rutledge FN, Delclos L: Postoperative treatment of early cancer of the ovary: A random trial between post-operative irradiation and chemotherapy. Natl Cancer Inst Monogr 42:149–153, 1975.
Hreshchyshyn MM, Park RC, Blessing JA, Norris HJ, Levy D, Lagasse LD, Creasman WT: The role of adjuvant therapy in Stage I ovarian cancer. Am J Obstet Gynecol 138:139–145, 1980.
Dembo AJ, Bush RS, DeBoer G. Letter to the Editor. Am J Obstet Gynecol 141:231, 1981.
Tobias JS, Griffiths CT: Management of ovarian carcinoma. Current concepts and future prospects. N Engl J Med 294:819–823, 1976 (Part I) and 294:877–882, 1976 (Part II).
Eltringham JR: Radiation therapy for ovarian carcinoma. Clin Obstet Gynecol 22:967–992, 1979.
Delclos L, Braun EJ, Herrera JR, Sampiere VA, Roosenbeek EV: Whole abdominal irradiation by Cobalt-60 moving-strip technique. Radiology 81:632–641, 1963.
Delclos L, Quinlan EJ: Malignant tumors of the ovary managed with postoperative mega-voltage irradiation. Radiology 93:659–663, 1969.
Smith JP, Rutledge F: Chemotherapy in the treatment of cancer of the ovary. Am J Obstet Gynecol 107:691–703, 1970.
Courtice FC, Harding J, Steinbeck AW: The removal of free red blood cells from the peritoneal cavity of animals. Aust J Exp Biol Med Sci 31:215–225, 1953.
Coates G, Bush RS, Aspin N: A study of ascites using lymphoscintigraphy with 99mTc-sulphur colloid. Radiology 107:577–583, 1973.
Delclos L, Dembo AJ: Ovaries. In: Textbook of Radiotherapy. Fletcher GH (ed). Philadelphia: Lea&Febiger, 1980, pp 834–851.
Fazekas JT, Maier JG: Irradiation of ovarian carcinomas: A prospective comparison of the open-field and moving-strip techniques. Am J Roentgenol 120:118–123, 1974.
Dembo AJ, Bush RS, Brown TC: Clinico-pathological correlates in ovarian cancer. Bulletin du Cancer (Paris), 69:292–297, 1982.
Dembo AJ, Brown TC, Bush RS, Sturgeon JFG: Prognostic significance of pathology subtype and differentiation in epithelial carcinoma of ovary (ECO). Proc Am Soc Clin Oncol, Abstract C408, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Dembo, A.J., Bush, R.S. (1983). Radiation Therapy of Ovarian Carcinoma. In: Griffiths, C.T., Fuller, A.F. (eds) Gynecologic Oncology. Cancer Treatment and Research, vol 10. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3852-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3852-9_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3854-3
Online ISBN: 978-1-4613-3852-9
eBook Packages: Springer Book Archive